01.12.2013 | Original Article
Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways
Erschienen in: Journal of Endocrinological Investigation | Ausgabe 11/2013
Einloggen, um Zugang zu erhalten